← Back to Search

Virtual Reality Vision Testing for Glaucoma

N/A
Recruiting
Led By Michael Chaglasian, OD
Research Sponsored by Envision Health Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range: 25-70 years
For normal subjects: Patient is free of any current or prior ophthalmic pathologies that would potentially cause visual field defects (e.g. retina pathology, glaucoma, cataracts, keratoconus)
Must not have
No past refractive eye surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Summary

This trial is looking at a new way to test the vision of patients with glaucoma using a Virtual Reality (VR) headset instead of the traditional Humphrey Field Analyzer (HFA). The VR

Who is the study for?
This trial is for individuals with glaucoma. It's testing a new way to check their field of vision using a Virtual Reality (VR) headset, which could be more comfortable and convenient than current methods.
What is being tested?
The study compares traditional visual field testing using the Humphrey Field Analyzer with a novel VR-based test. The goal is to see if the VR test can accurately assess visual function in both healthy eyes and those affected by glaucoma.
What are the potential side effects?
Since this trial involves non-invasive perimetric testing, side effects are minimal but may include discomfort from wearing the VR headset or eye fatigue from the tests.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 25 and 70 years old.
Select...
I have no eye diseases that could affect my vision.
Select...
I haven't had eye surgery in the last 6 months, except for glaucoma or cataract surgery.
Select...
I have been diagnosed with primary open-angle glaucoma.
Select...
I don't have any eye conditions that could affect my vision.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have never had surgery to correct my vision.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual field perimetry foveal sensitivity
Visual field perimetry light sensitivity
Visual field perimetry test duration
Secondary study objectives
Optical Coherence Tomography (OCT)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Healthy subjectsExperimental Treatment1 Intervention
30 healthy subjects
Group II: Glaucoma subjectsExperimental Treatment1 Intervention
30 glaucoma patients, 10 mild, 10 moderate, 10 severe

Find a Location

Who is running the clinical trial?

Envision Health Technologies, Inc.Lead Sponsor
Illinois College of OptometryOTHER
7 Previous Clinical Trials
282 Total Patients Enrolled
Michael Chaglasian, ODPrincipal InvestigatorIllinois College of Optometry
2 Previous Clinical Trials
490 Total Patients Enrolled
~40 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top